FATOUMATA CAMARA: Open Payments
NPI 1033733670 · BALA CYNWYD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,853 in 188 payments from 21 companies in 2025. Trend: 2023 $3,671 · 2024 $5,276 · 2025 $4,853
Food & beverage: $4,853
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 53 | $1,623 |
| LEO Pharma Inc. | 6 | $520 |
| Novartis Pharmaceuticals Corporation | 11 | $420 |
| PFIZER INC. | 11 | $364 |
| ABBVIE INC. | 25 | $346 |
| GENZYME CORPORATION | 10 | $314 |
| Regeneron Healthcare Solutions, Inc. | 13 | $256 |
| Lilly USA, LLC | 9 | $183 |
| UCB, Inc. | 5 | $165 |
| Galderma Laboratories, L.P. | 15 | $146 |
Products named: TREMFYA, DUPIXENT, ADBRY, COSENTYX, CIBINQO, SKYRIZI, Bimzelx, RINVOQ.
Industry payments across PA — which companies pay providers there.
